
Global Drug-Eluting Balloons Market Research Report 2021
Discover the latest insights into the booming Drug Eluting Balloons Market. This report analyzes market size, growth trends (CAGR ), key players, and regional performance, offering valuable data for investors and industry professionals. Explore market drivers, restraints, and future projections for -.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Research Predicts that Drug-Eluting Balloons Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.
Global Drug-Eluting Balloons Market Overview:
Global Drug-Eluting Balloons Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Drug-Eluting Balloons involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Impact of COVID-19 on Drug-Eluting Balloons Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Drug-Eluting Balloons market in 2020.
Global Drug-Eluting Balloons Market Segmentation
By Type, Drug-Eluting Balloons market has been segmented into:
Semi-Compliant Balloons
Non-Compliant Balloons
By Application, Drug-Eluting Balloons market has been segmented into:
Treatment of In-stent Restenosis (ISR)
Treatment of Small Vessel Disease (SVD)
Treatment of Bifurcation Stenoses
Treatment of Primary Coronary Artery Disease
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Top Key Players Covered in Drug-Eluting Balloons market are:
Boston Scientific
Medtronic
Cook Medical
C.R. Bard
B. Braun
Eurocor GmbH
Blue Medical
Bayer
Aachen Resonance
Acrostak
1. Market Overview of Drug-Eluting Balloons
1.1 Drug-Eluting Balloons Market Overview
1.1.1 Drug-Eluting Balloons Product Scope
1.1.2 Market Status and Outlook
1.2 Drug-Eluting Balloons Market Size by Regions: 2015 VS 2021 VS 2026
1.3 Drug-Eluting Balloons Historic Market Size by Regions (2015-2020)
1.4 Drug-Eluting Balloons Forecasted Market Size by Regions (2021-2026)
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Drug-Eluting Balloons Sales Market by Type (2015-2026)
2.1 Global Drug-Eluting Balloons Historic Market Size by Type (2015-2020)
2.2 Global Drug-Eluting Balloons Forecasted Market Size by Type (2021-2026)
2.3 Semi-Compliant Balloons
2.4 Non-Compliant Balloons
3. Covid-19 Impact Drug-Eluting Balloons Sales Market by Application (2015-2026)
3.1 Global Drug-Eluting Balloons Historic Market Size by Application (2015-2020)
3.2 Global Drug-Eluting Balloons Forecasted Market Size by Application (2021-2026)
3.3 Treatment of In-stent Restenosis (ISR)
3.4 Treatment of Small Vessel Disease (SVD)
3.5 Treatment of Bifurcation Stenoses
3.6 Treatment of Primary Coronary Artery Disease
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Drug-Eluting Balloons Production Capacity Market Share by Manufacturers (2015-2020)
4.2 Global Drug-Eluting Balloons Revenue Market Share by Manufacturers (2015-2020)
4.3 Global Drug-Eluting Balloons Average Price by Manufacturers (2015-2020)
5. Company Profiles and Key Figures in Drug-Eluting Balloons Business
5.1 Boston Scientific
5.1.1 Boston Scientific Company Profile
5.1.2 Boston Scientific Drug-Eluting Balloons Product Specification
5.1.3 Boston Scientific Drug-Eluting Balloons Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.2 Medtronic
5.2.1 Medtronic Company Profile
5.2.2 Medtronic Drug-Eluting Balloons Product Specification
5.2.3 Medtronic Drug-Eluting Balloons Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.3 Cook Medical
5.3.1 Cook Medical Company Profile
5.3.2 Cook Medical Drug-Eluting Balloons Product Specification
5.3.3 Cook Medical Drug-Eluting Balloons Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.4 C.R. Bard
5.4.1 C.R. Bard Company Profile
5.4.2 C.R. Bard Drug-Eluting Balloons Product Specification
5.4.3 C.R. Bard Drug-Eluting Balloons Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.5 B. Braun
5.5.1 B. Braun Company Profile
5.5.2 B. Braun Drug-Eluting Balloons Product Specification
5.5.3 B. Braun Drug-Eluting Balloons Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.6 Eurocor GmbH
5.6.1 Eurocor GmbH Company Profile
5.6.2 Eurocor GmbH Drug-Eluting Balloons Product Specification
5.6.3 Eurocor GmbH Drug-Eluting Balloons Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.7 Blue Medical
5.7.1 Blue Medical Company Profile
5.7.2 Blue Medical Drug-Eluting Balloons Product Specification
5.7.3 Blue Medical Drug-Eluting Balloons Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.8 Bayer
5.8.1 Bayer Company Profile
5.8.2 Bayer Drug-Eluting Balloons Product Specification
5.8.3 Bayer Drug-Eluting Balloons Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.9 Aachen Resonance
5.9.1 Aachen Resonance Company Profile
5.9.2 Aachen Resonance Drug-Eluting Balloons Product Specification
5.9.3 Aachen Resonance Drug-Eluting Balloons Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.10 Acrostak
5.10.1 Acrostak Company Profile
5.10.2 Acrostak Drug-Eluting Balloons Product Specification
5.10.3 Acrostak Drug-Eluting Balloons Production Capacity, Revenue, Price and Gross Margin (2015-2020)
6. North America
6.1 North America Drug-Eluting Balloons Market Size (2015-2026)
6.2 North America Drug-Eluting Balloons Key Players in North America (2015-2020)
6.3 North America Drug-Eluting Balloons Market Size by Type (2015-2020)
6.4 North America Drug-Eluting Balloons Market Size by Application (2015-2020)
7. East Asia
7.1 East Asia Drug-Eluting Balloons Market Size (2015-2026)
7.2 East Asia Drug-Eluting Balloons Key Players in North America (2015-2020)
7.3 East Asia Drug-Eluting Balloons Market Size by Type (2015-2020)
7.4 East Asia Drug-Eluting Balloons Market Size by Application (2015-2020)
8. Europe
8.1 Europe Drug-Eluting Balloons Market Size (2015-2026)
8.2 Europe Drug-Eluting Balloons Key Players in North America (2015-2020)
8.3 Europe Drug-Eluting Balloons Market Size by Type (2015-2020)
8.4 Europe Drug-Eluting Balloons Market Size by Application (2015-2020)
9. South Asia
9.1 South Asia Drug-Eluting Balloons Market Size (2015-2026)
9.2 South Asia Drug-Eluting Balloons Key Players in North America (2015-2020)
9.3 South Asia Drug-Eluting Balloons Market Size by Type (2015-2020)
9.4 South Asia Drug-Eluting Balloons Market Size by Application (2015-2020)
10. Southeast Asia
10.1 Southeast Asia Drug-Eluting Balloons Market Size (2015-2026)
10.2 Southeast Asia Drug-Eluting Balloons Key Players in North America (2015-2020)
10.3 Southeast Asia Drug-Eluting Balloons Market Size by Type (2015-2020)
10.4 Southeast Asia Drug-Eluting Balloons Market Size by Application (2015-2020)
11. Middle East
11.1 Middle East Drug-Eluting Balloons Market Size (2015-2026)
11.2 Middle East Drug-Eluting Balloons Key Players in North America (2015-2020)
11.3 Middle East Drug-Eluting Balloons Market Size by Type (2015-2020)
11.4 Middle East Drug-Eluting Balloons Market Size by Application (2015-2020)
12. Africa
12.1 Africa Drug-Eluting Balloons Market Size (2015-2026)
12.2 Africa Drug-Eluting Balloons Key Players in North America (2015-2020)
12.3 Africa Drug-Eluting Balloons Market Size by Type (2015-2020)
12.4 Africa Drug-Eluting Balloons Market Size by Application (2015-2020)
13. Oceania
13.1 Oceania Drug-Eluting Balloons Market Size (2015-2026)
13.2 Oceania Drug-Eluting Balloons Key Players in North America (2015-2020)
13.3 Oceania Drug-Eluting Balloons Market Size by Type (2015-2020)
13.4 Oceania Drug-Eluting Balloons Market Size by Application (2015-2020)
14. South America
14.1 South America Drug-Eluting Balloons Market Size (2015-2026)
14.2 South America Drug-Eluting Balloons Key Players in North America (2015-2020)
14.3 South America Drug-Eluting Balloons Market Size by Type (2015-2020)
14.4 South America Drug-Eluting Balloons Market Size by Application (2015-2020)
15. Rest of the World
15.1 Rest of the World Drug-Eluting Balloons Market Size (2015-2026)
15.2 Rest of the World Drug-Eluting Balloons Key Players in North America (2015-2020)
15.3 Rest of the World Drug-Eluting Balloons Market Size by Type (2015-2020)
15.4 Rest of the World Drug-Eluting Balloons Market Size by Application (2015-2020)
16 Drug-Eluting Balloons Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porter’s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
Research Methodology:
Drug Eluting Balloons Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|